Gina M. Wallar - 05 Jul 2021 Form 3 Insider Report for NEOGENOMICS INC (NEO)

Role
President, Pharma Services
Signature
/s/ Gina M. Wallar
Issuer symbol
NEO
Transactions as of
05 Jul 2021
Net transactions value
$0
Form type
3
Filing time
07 Jul 2021, 18:33:51 UTC
Next filing
30 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NEO Common Stock 4,117 05 Jul 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NEO Stock Option (Right to Buy) 05 Jul 2021 Common Stock 6,667 $9.22 Direct F1
holding NEO Stock Option (Right to Buy) 05 Jul 2021 Common Stock 8,334 $13.87 Direct F2
holding NEO Stock Option (Right to Buy) 05 Jul 2021 Common Stock 7,153 $20.83 Direct F3
holding NEO Stock Option (Right to Buy) 05 Jul 2021 Common Stock 7,879 $27.34 Direct F4
holding NEO Stock Option (Right to Buy) 05 Jul 2021 Common Stock 8,595 $48.99 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F2 On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F3 On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F4 On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F5 On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.